🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Photosensitivity

Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults NCT06743373NA1 site📍 Pittsburgh University of Pittsburgh · Tests: Cannabis Discontinuation SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites📍 Nijmegen📍 Maastricht📍 Amsterdam Leiden University Medical Center Natural History Study for DNA Repair Disorders NCT05484570n/a1 site📍 Minneapolis University of Minnesota · Tests: Interval History, Physical Examination, ECAB Assessment, Gait Assessment, Specimen Sample Collection Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury NCT06109909NA1 site📍 Boston VA Office of Research and Development · Tests: Micro Current Neurofeedback Device using Low-Frequency Pulse-Based Transcranial Electrical Stimulation Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects NCT04520217Phase 11 site📍 Fairborn Wright State University · Tests: 4% Imipramine Cream, Base Cream Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria NCT06865651Phase 217 sites📍 North Miami Beach📍 Glenview📍 Grenoble Novartis Pharmaceuticals · Tests: Remibrutinib, Placebo A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP NCT07024316Phase 1, Phase 21 site📍 Cleveland Atlas Molecular Pharma · Tests: ATL-001 (Ciclopirox oral solution) Skin Type Determination Using Image Artificial Intelligence NCT07765303n/a13 sites📍 Brisbane📍 Porto Alegre📍 Santiago Region Skane · Tests: Skin imaging and skin characteristic assessment
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy